Death (any cause) · adults and children who have IgA nephropathy proven on renal biopsy
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Infection · adults and children who have IgA nephropathy proven on renal biopsy
It is very uncertain whether mizoribine regimen changes infection compared with no mizoribine regimen (very low certainty).
1 finding from 1 review
Malignancy · adults and children who have IgA nephropathy proven on renal biopsy
It is very uncertain whether mizoribine regimen changes malignancy compared with no mizoribine regimen (very low certainty).
1 finding from 1 review
End‐stage renal disease · adults and children who have IgA nephropathy proven on renal biopsy
It is very uncertain whether leflunomide regimen changes end‐stage kidney disease compared with no leflunomide regimen (very low certainty).
1 finding from 1 review
Complete remission · adults and children who have IgA nephropathy proven on renal biopsy
It is very uncertain whether leflunomide regimen changes complete remission compared with no leflunomide regimen (very low certainty).
1 finding from 1 review
GFR loss ≥ 50% · adults and children who have IgA nephropathy proven on renal biopsy
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Annual GFR loss (mL/min/1.73 m2) · adults and children who have IgA nephropathy proven on renal biopsy
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Annual GFR loss (mL/min/1.73 m2) · adults and children who have IgA nephropathy proven on renal biopsy
1 finding from 1 review
Death (any cause) · adults and children who have IgA nephropathy proven on renal biopsy
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Infection · adults and children who have IgA nephropathy proven on renal biopsy
It is very uncertain whether leflunomide regimen changes infection compared with no leflunomide regimen (very low certainty).
1 finding from 1 review
Malignancy · adults and children who have IgA nephropathy proven on renal biopsy
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Death (any cause) (median · adults and children who have IgA nephropathy proven on renal biopsy
It is very uncertain whether systemic corticosteroid changes death (any cause) Median compared with no corticosteroid regimen (very low certainty).
1 finding from 1 review
Infection Median · adults and children who have IgA nephropathy proven on renal biopsy
It is very uncertain whether systemic corticosteroid changes infection Median compared with no corticosteroid regimen (very low certainty).
1 finding from 1 review
Malignancy · adults and children who have IgA nephropathy proven on renal biopsy
It is very uncertain whether systemic corticosteroid changes malignancy compared with no corticosteroid regimen (very low certainty).
1 finding from 1 review
End‐stage renal disease · adults and children who have IgA nephropathy proven on renal biopsy
Cytotoxic regimen showed no clear difference in end‐stage kidney disease compared with no cytotoxic regimen (low certainty).
1 finding from 1 review
Complete remission · adults and children who have IgA nephropathy proven on renal biopsy
It is very uncertain whether cytotoxic regimen changes complete remission compared with no cytotoxic regimen (very low certainty).
1 finding from 1 review
Kidney failure · proteinuric CKD
It is very uncertain whether aldosterone antagonists changes kidney failure compared with placebo or standard care (very low certainty).
1 finding from 1 review
Hyperkalaemia · proteinuric CKD
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Death · proteinuric CKD
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Cardiovascular events · proteinuric CKD
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found